Anti-gp41 antibodies inhibit infection and transcytosis of HIV-1 infectious molecular clones expressing transmitted/founder envelopes

Por Jain, S, Ochsenbauer, C, Kappes, JC, Rosenthal, KL
Publicado em 2012

Antibody-mediated inhibition of HIV-1 elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults

Por Joachim A, Nilsson C, Aboud S, Lyamuya EF, Robb M, Marovich M, Ochsenbauer C, Wahren B, Sandström E, Biberfeld G, Ferrari G, Polonis VR
Publicado em 2012-09-01

Antibody-mediated inhibition of HIV-1 elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults

Por Joachim, A, Nilsson, C, Aboud, S, Lyamuya, EF, Robb, M, Marovich, M, Ochsenbauer, C, Wahren, B, Sandström, E, Biberfeld, G, Ferrari, G, Polonis, VR
Publicado em 2012

Optimization and validation of the HIV-1 neutralizing antibody assay in A3R5 cells

Por Sarzotti-Kelsoe, M, Daniell, X, Todd, CA, Bilska, M, LaBranche, C, Perez, LG, Ochsenbauer, C, Kappes, J, Rountree, W, Ozaki, DA, Kim, JH, McLinden, R, Denny, T, Montefiori, DC
Publicado em 2012

Antigenicity and immunogenicity of a novel, acute HIV-1 Tanzanian subtype C gp145 envelope protein for clinical development

Por Polonis, V, Wieczorek, L, Kalyanaraman, V, Matyas, G, Whitney, S, Williams, C, Tovanabutra, S, Sanders-Buell, E, Wesberry, M, Ochsenbauer, C, Chenine, A, Rao, M, Tong, T, Alving, C, Cheng, H, Zolla-Pazner, S, Michael, N, VanCott, T, Marovich, M
Publicado em 2012

Vaccine-induced ADCC-mediating antibodies target unique and overlapping envelope epitopes

Por Pollara, J, Bonsignori, M, Moody, M, Alam, M, Liao, H, Hwang, K, Pickeral, J, Kappes, J, Ochsenbauer, C, Soderberg, K, Gurley, TC, Kozink, DM, Marshall, DJ, Whitesides, JF, Montefiori, D, Robinson, JE, Kaewkungwal, J, Nitayaphan, S, Pitisuttithum, P, Rerks-Ngarm, S, Kim, J, Michael, N, Tomaras, G, Haynes, BF, Ferrari, G
Publicado em 2012

Multiple antibody specificities (gp41, V1V2, and V3) elicited in the phase II multiclade (A, B, C) HIV-1 DNA prime, rAd5 boost vaccine trial

Por Williams, WB, Jones, K, Krambrink, A, Grove, D, Liu, P, Yates, NL, Moody, MA, Ferrari, G, Pollara, J, Moodie, Z, Morgan, CA, Liao, H, Montefiori, DC, Ochsenbauer, C, Kappes, J, Hammer, S, Mascola, J, Koup, R, Corey, L, Nabel, G, Gilbert, P, Churchyard, G, Keefer, M, Graham, BS, Haynes, BF, Tomaras, GD
Publicado em 2012